• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Colotal
    / Perrigo


    Active Ingredient

    Status in Israel
    OTC

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Tablets

    50 X 135 mg

    full basket chart 7703 3594

    Related information


    Dosage

    Adults: Colotal tablets should be swallowed with a sufficient amount of water (at least 100 ml water). Do not chew.
    One 135 mg tablet three times daily; to be given approx. 20 minutes before
    meals.
    Paediatric Population: Colotal 135 mg tablets are not recommended for use in children and adolescents below 18, due to insufficient data on safety and efficacy.


    Indications

    Symptomatic treatment of abdominal pain, bloating, abdominal distention, flatulence, other symptoms of IBS, gastro-intestinal spasm secondary to organic disease as in diverticulosis, diverticulitis, Crohn’s disease.


    Contra-Indications

    Hypersensitivity.


    Special Precautions

    Pregnancy and lactation.


    Side Effects

    Rare cases of allergic reactions.


    Drug interactions

    Phenothiazines, antihistamines, antidepressants, amantadine, disopyramide, methocarbaol, nefopam. Domperidone, metoclopramide, ketonazole, glyceryl trinitrate (sublingual).


    Manufacturer
    Perrigo Israel
    CLOSE